Results 31 to 40 of about 13,979 (215)

BLCA prognostic model creation and validation based on immune gene-metabolic gene combination

Discover Oncology, 2023
Abstract Background Bladder cancer (BLCA) is a prevalent urinary system malignancy. Understanding the interplay of immunological and metabolic genes in BLCA is crucial for prognosis and treatment. Methods Immune/metabolism genes were extracted, their expression profiles ...
Shao-Yu Yue, Di Niu, Xian-Hong Liu, Wei-Yi Li, Ke Ding, Hong-Ye Fang, Xin-Dong Wu, Chun Li, Yu Guan, He-Xi Du   +9 more
openaire   +3 more sources

Image1_The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA).TIF

, 2022
Introduction: The role of pyroptosis and its effects on tumor-infiltrating cells (TICs) in the pathogenesis and treatment outcomes of patients with bladder urothelial carcinoma (BLCA) remains unclear.Methods: We conducted a bioinformatics analysis on the
Litong Zhu (6578963), Ming Xie (420493), Joanne W. Y. Chiu (13115742), Wayne Lam (355299), Desmond Y. H. Yap (13115745), Ruiyan Xie (13115739)   +5 more
core   +1 more source

IMPLEMENTASI BLENDED LEARNING BY THE CONSTRUCTIVE APPROACH (BLCA) DALAM PEMBELAJARAN INTERAKSI MANUSIA DAN KOMPUTER [PDF]

, 2014
Implementasi blended learning by the constructive approach (BLCA) dalam pembelajaran interaksi manusia dan komputer bertujuan untuk meningkatkan pemahaman konsep dan kemandirian belajar dalam pembelajaran interaksi manusia dan komputer (IMK).
C. Asri Budiningsih, Dian Wahyuningsih, Wahyuningsih, Dian, Budiningsih, C. Asri   +3 more
core   +1 more source

ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts [PDF]

, 2023
Background: ACSMs play critical roles in lipid metabolism; however, their immunological function within the tumor microenvironment (TME) remains unclear, especially that of ACSM6. In this study, we investigate the latent effect of ACSM6 on bladder cancer
Tiezheng Qi, Yiyan Yao, Dingshan Deng, Zhiwei Li, Zuowei Wu, Bolong Liu   +5 more
core   +1 more source

Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer

Metabolites, 2022
Bladder Cancer (BLCA) is the ninth most frequently diagnosed cancer globally and the sixth most common cancer in the US. African Americans (AA) exhibit half the BLCA incidence compared to European Americans (EA), but they have a 70% higher risk of cancer-
Karthik Reddy Kami Reddy, Danthasinghe Waduge Badrajee Piyarathna, Abu Hena Mostafa Kamal, Vasanta Putluri, Shiva Shankar Ravi, Roni J. Bollag, Martha K. Terris, Yair Lotan, Nagireddy Putluri   +8 more
doaj   +1 more source

Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling

Frontiers in Cell and Developmental Biology, 2022
Bladder cancer (BLCA) is a tumor that possesses significant heterogeneity, and the tumor microenvironment (TME) plays an important role in the development of BLCA.
YiHeng Du, YiHeng Du, YiQun Sui, Jin Cao, Xiang Jiang, Yi Wang, Jiang Yu, Bo Wang, XiZhi Wang, BoXin Xue   +9 more
doaj   +1 more source

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer

Frontiers in Genetics, 2021
SHMT2 was overexpressed in many tumors, however, the role of SHMT2 in bladder cancer (BLCA) remains unclear. We first analyzed the expression pattern of SHMT2 in BLCA using the TNMplot, Oncomine, the Cancer Genome Atlas (TCGA), and the Gene Expression ...
Peng Zhang, Qian Yang
doaj   +1 more source

Image2_A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts.TIF

, 2023
Background: Although the durable efficacy of immune checkpoint inhibitors (ICIs) in BLCA has been confirmed in numerous studies, not all patients benefit from their application in the clinic.
Huihuang Li (1701952), Xiaowen Li (317720), Tiezheng Qi (11271606), Yuanqing Dai (15407567), Neng Liu (2118667), Dingshan Deng (8910740)   +5 more
core   +1 more source

Table2_A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts.XLSX

, 2023
Background: Although the durable efficacy of immune checkpoint inhibitors (ICIs) in BLCA has been confirmed in numerous studies, not all patients benefit from their application in the clinic.
Huihuang Li (1701952), Xiaowen Li (317720), Tiezheng Qi (11271606), Yuanqing Dai (15407567), Neng Liu (2118667), Dingshan Deng (8910740)   +5 more
core   +1 more source

Image1_A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts.TIF

, 2023
Background: Although the durable efficacy of immune checkpoint inhibitors (ICIs) in BLCA has been confirmed in numerous studies, not all patients benefit from their application in the clinic.
Huihuang Li (1701952), Xiaowen Li (317720), Tiezheng Qi (11271606), Yuanqing Dai (15407567), Neng Liu (2118667), Dingshan Deng (8910740)   +5 more
core   +1 more source